January 18, 2000 Civil Rights Attorney Morris Dees to Speak Jan. 19 Ohio Univ. Named One of America's 100 Best College Buys Ohio University Signs Exchange Agreement with Brazilians

• Contact the Registrar's Office for information about the following:
  • Last day to register for Winter Quarter
  • Last day to add a class for Winter Quarter
  • Last day to apply for the pass/fail grading option through your academic dean's student services office or regional campus student services office for Winter Quarter class
  • Last day to change grading option (credit to audit/audit to credit or pass/fail to regular grade option/regular grade option to pass/fail) for Winter Quarter class
  • Last day to drop a class for Winter Quarter without receiving a grade (WP/WF)
  • Last day to receive partial refund of registration fees (80%) for complete withdrawal from the university for Winter Quarter
    
    
• "Painters Who Make Prints" exhibit continues at the Kennedy Museum of Art.
  
  
• For more, please visit the online Calendar of Events. Also, please check the Fun Stuff page for a completed listing of this long weekend's events.
  

• Seniors, Sign Up Now for the Senior Class Trip and for Free Yearbook Photos
  
  
• Camois to Hold Free Reading Jan. 19
  
  
• Training for Web-based Teaching Tool Now Available
  
  
• Important Information for DialNet Users
  
  
• Microsoft Products Available to Ohio University Students, Departments, and Employees
  
  
• How to Get Your Bobcat Basketball Tickets
  
  
• Transportation from Athens to Columbus available

Dutch Endocrinologist to Lecture on Growth Hormone January 20 Dr. A.J. van der Lely, a Dutch endocrinologist, will deliver a lecture about the clinical aspects and trials of growth hormone antagonists at noon Thursday, January 20, in Irvine Hall, Room 199. Van der Lely, Head of the Clinical Research Unit at the Erasmus University Medical Centre Academic Hospital in Rotterdam, The Netherlands, will discuss results from a clinical trial to study the blockade of the growth hormone receptor in men, as well as the clinical implications of using growth hormone antagonists. An Ohio University research team, led by John Kopchick, Goll-Ohio Professor of molecular biology, discovered growth hormone antagonists more than 10 years ago in labs in the university's Edison Biotechnology Institute. Ohio University recently received the third U.S. patent in a series on the technology, which serves as the basis for the drug pegvisomant. This summer, Texas scientists successfully used the drug in clinical trials to treat acromegaly, a disease that affects about 40,000 people worldwide. For more information, please read the full text of this news release.